Menopause-Associated Vasomotor Symptom Treatment With Elinzanetant
22/08/2024
0:00
11:25
Nonhormonal treatments for menopausal vasomotor symptoms may benefit symptomatic patients who cannot take or prefer to avoid systemic hormones. Author JoAnn V. Pinkerton, MD, MSCP, discusses the efficacy and safety of elinzanetant for the treatment of moderate to severe vasomotor symptoms associated with menopause with JAMA Deputy Editor Linda Brubaker, MD, MS.
Related Content:
D'autres épisodes de "JAMA Author Interviews"
Ne ratez aucun épisode de “JAMA Author Interviews” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.